淋巴功能障碍是帕金森病中脑铁沉积的潜在驱动因素
Kaidong Chen1, Yi Ji1, Li Zhang2
1Department of Radiology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi 214023, China.
Brain communications
|October 10, 2025
概括
帕金森病患者表现出桃体体积 (CPV) 增加和淋巴功能降低,导致大脑铁沉积增加. 这些因素与疾病的严重程度和症状相关,这表明了新的治疗点.
科学领域:
- 神经成像是一种神经成像.
- 神经学 神经学
- 生物标志物 生物标志物
背景情况:
- 大脑中的铁沉积是帕金森病 (PD) 的标志.
- 患有PD的患者表现出放大胆膜体积 (CPV) 和淋巴功能受损.
- 通过CPV和淋巴系统的铁清除受损在PD铁积累中的作用尚不清楚.
研究的目的:
- 在PD中研究大脑铁沉积和淋巴功能障碍之间的关系.
- 探索这些关联的临床相关性.
- 假设受损的淋巴清除有助于PD的病态铁积累.
主要方法:
- 65名PD患者和38名对照人群的横截面研究.
- 多式核磁共振成像用于评估CPV,ALPS指数 (淋巴功能) 和铁水平 (定量敏感性映射).
- 临床评估 (运动,认知,精神) 和统计分析,包括相关性和调解.
主要成果:
- 与对照人群相比,PD患者的CPV扩大,ALPS指数降低,黑质体,红核和骨中铁含量增加.
- CPV扩大与ALPS指数负相关.
- 淋巴功能障碍 (CPV/ALPS) 与区域铁沉积相关,特别是CPV和黑色物质铁.
- 调解分析显示,CPV通过ALPS和putamen铁对日常生活和精神症状产生影响.
- 综合诊断模型实现了PD检测的高精度 (AUC=0.972).
结论:
- 扩大的CPV和降低的ALPS指数与帕金森病中的病理铁沉积有关.
- 这些神经成像生物标志物与运动,认知和精神症状相关,表明它们在疾病进展中的作用.
- 多模式诊断方法对PD检测具有很高的准确性.
- 淋巴细胞调节和铁化代表了PD的潜在治疗策略.
更多相关视频
09:27Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
18.0K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
8.2K
相关概念视频
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Parkinson's Disease: Treatment
983
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
983
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
